One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2019-122141
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 5 |
Affiliation: Turku University Hospital, Uppsala University, Oslo University Hospital, Helsingborgs lasarett, Aarhus University Hospital, Örebro University Hospital, Norwegian University of Science and Technology, Karolinska University Hospital, Karolinska Institutet, Aalborg University Hospital, Odense University Hospital, Herlev Hospital, Skåne University Hospital, Lund University, Copenhagen University Hospital, Haukeland University Hospital, Zealand University Hospital, Rigshospitalet, Vilnius University, Sahlgrenska University Hospital
A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance after Induction with Carfilzomib-Cyclophosphamide-Dexamethasone in Salvage ASCT in Multiple Myeloma: A Trial By the Nordic Myeloma Study Group
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
